Latest | F'cast | |
---|---|---|
Div Yield | 1.0% | |
Div Cover | 3.8 | |
Op Mrgn | 9.1% | |
ROCE | 8.2% |
Latest | F'cast | |
---|---|---|
P/E | 26.9 | |
PEG | 2.4 | |
Pr/Revenue | 0.6 | |
Pr/Book | 1.3 |
Latest | F'cast | |
---|---|---|
Revenue | 11.2% | |
PBT | 10.7% | |
EPS | 11.4% | |
DPS | 9.5% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 919.90 | (231.00) | (5.20)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1,106.20 | (1.90) | (7.10)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 1,198.50 | 3.90 | 4.20p | 54.5 | n/a | n/a | 0.50p | 0.2% |
31-Dec-23 | 1,359.00 | 34.60 | 7.90p | 28.5 | 0.3 | +88% | 2.10p | 0.9% |
31-Dec-24 | 1,511.20 | 38.30 | 8.80p | 25.6 | 2.3 | +11% | 2.30p | 1.0% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1,594.53 | 158.93 | 9.75p | 24.3 | 2.2 | +11% | 2.60p | 0.0% |
31-Dec-26 | 1,682.28 | 186.78 | 15.06p | 15.7 | 0.3 | +54% | 3.92p | 0.0% |
31-Dec-27 | 1,771.19 | 210.32 | 19.47p | 12.2 | 0.4 | +29% | 5.02p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Form 8.3 - The Vanguard Group, Inc.: Spire Healt... | 22-Sep-2025 | 19:13 | EQS Group |
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIR... | 22-Sep-2025 | 10:27 | GlobeNewswire NA |
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIR... | 09-Jun-2021 | 12:30 | GlobeNewswire NA |
No recent information was found.
Spire Healthcare considers sale after investor p... | 19-Sep-2025 | Times |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 237.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 246.50 |
52 Week Low | 171.60 |
Volume | 28,785 |
Shares Issued | 399.39m |
Market Cap | £946.55m |
Strong Buy | 4 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Time | Volume / Share Price |
09:37 | 288 @ 237.00p |
09:37 | 562 @ 237.50p |
09:37 | 562 @ 237.00p |
09:28 | 1,521 @ 237.50p |
09:20 | 80 @ 238.00p |
CEO | Justin Ash |
CFO | Harbant Samra |
You are here: research